This mechanism was validated in AD models, where transgenic mice exhibited significantly elevated PFKFB3 expression following amyloid plaque deposition, accompanied by astrocyte activation and neuronal dysfunction (32). The gene discussed is PFKFB3; the disease is Alzheimer disease.